Despite promising Phase II data, there was no difference in overall survival between the patients who received Canvaxin and the patients who received placebo in the randomized Phase III trial of ...

We report our experience with more than 1,000 patients who underwent patch testing with metals during the past decade at Mayo Clinic. Many metals with high reaction rates (eg, gold, nickel, and ...